Idera Pharmaceuticals, Inc. (IDRA) News Headlines

▮ More

Date

Headline

10/21/2019 7:11:04 AM Idera Announces New U.S. Patent For Tilsotolimod Through September 2037

9/30/2019 7:40:34 AM Idera Announces Initiation Of Phase 2 Trial, ILLUMINATE-206

9/4/2019 7:10:00 AM Idera Pharma Announces Immuno-Oncology Clinical Research Collaboration With AbbVie

7/23/2019 7:37:08 AM Idera Names Elizabeth Tarka Chief Medical Officer; Promotes John Kirby To CFO

4/10/2019 7:09:07 AM Idera Pharma Provides Corporate Update

2/27/2019 7:13:43 AM Idera Pharma Completes Enrollment Into The ILLUMINATE-204 Trial Of The Combination Of Tilsotolimod And Ipilimumab

1/2/2019 9:16:45 PM PRAN Gets New Lease Of Life, ADIL On Watch, GNPX Abuzz

12/19/2018 8:38:53 PM ADIL On The Job, ADRO Teams Up With LLY, So Long CIVI

12/18/2018 4:08:27 PM Idera Pharmaceuticals Appoints Carol Schafer To Its Board Of Directors

12/14/2018 7:07:16 AM Idera Pharma Presents Clinical Update From ILLUMINATE-204 Trial Of Combination Of Tilsotolimod And Ipilimumab

12/13/2018 12:03:22 AM AGTC Slumps After-hrs, NBIX Fails To Strike GOLD, IDRA To Report Data On Dec.14

9/18/2018 4:02:06 PM Idera Pharmaceuticals Appoints Howard Pien To Its Board Of Directors

8/14/2018 8:52:18 PM XERS Up 36% This Month, EVFM On Fast Track, NDRA Hitting Right Notes

8/13/2018 9:36:12 PM XBIO To Report Phase 2 Data This Year, VNRX Abuzz, ATRS To Face FDA In Sep

8/9/2018 8:46:06 PM ACER Already Up 61% This Month, CTXR Recoups Some Losses, Time To Check CKPT

8/2/2018 4:36:44 PM Idera Pharmaceuticals Q2 Loss/share $0.59 Vs. Loss $1.15 Year Ago

7/31/2018 11:04:39 PM MYND Gives Back Gains, RSLS Hits New Low, IDRA Has Its Work Cut Out

7/16/2018 6:21:10 AM Wedbush Is Lowering Idera Pharmaceuticals, Inc. (IDRA) FY18 Estimate To -0.40 From -0.37

7/16/2018 6:20:54 AM Wedbush Is Cutting Idera Pharmaceuticals, Inc. (IDRA) Q4 18 Estimate To -0.11 From -0.10

7/16/2018 6:20:20 AM Wedbush Is Increasing Idera Pharmaceuticals, Inc. (IDRA) Q3 18 Estimate To -0.08 From -0.09